Accessibility Menu
Otsuka logo

Otsuka(OTC) OTSKY

Market Cap$36.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+16%
5 Year+90%
1 Year+46%
1 Month+4%
$34.41
-3.97%
-1.42Today
Otsuka last closing stock price
MetricPriceDate
Last closeUSD 34.412026-07-31
Otsuka stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.14%USD 34.022026-07-24
1 month+4.46%USD 32.942026-07-01
3 month-3.27%USD 35.572026-05-01
Year to date+21.45%USD 28.332025-12-31
1 year+46.3%USD 23.522025-07-31
3 year+95.3%USD 17.622023-08-01
5 year+89.7%USD 18.142021-07-30
Since inception+16.16%USD 29.622012-06-21

Otsuka Financials at a Glance

Market Cap

$36.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥2.66T

Net Income (TTM)

¥411.93B

EPS (TTM)

$2.49

P/E Ratio

14.50

Dividend

$0.22

Beta (Volatility)

0.40 (Low)

Price

$34.41

Volume

50,665

Open

$35.62

Previous Close

$34.41

Daily Range

$34.04 - $35.82

52-Week Range

$24.91 - $37.52

Estimated Earnings Date

Oct 30, 2026

OTSKY News

Hands holding some pills from a bottle

5 Best Psychedelic Stocks for 2026 and How to Invest

Keith SpeightsJul 10, 2026
Person in a lab gazing into a microscope

Why Vera Therapeutics Stock Rocked the Market on Tuesday

Eric VolkmanDec 2, 2025
three scientists work in laboratory with one looking down a microscope

This Big Pharma Company Is Becoming a Psychedelics Stock, but Don't Buy It (Yet)

Alex CarchidiSep 11, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Otsuka

Otsuka Holdings Co., Ltd. is a diversified healthcare company based in Tokyo, Japan, focusing on pharmaceuticals, nutraceuticals, and consumer products. The company operates through various segments, including therapeutic drugs, nutrition products, and functional chemicals, aiming to improve health and well-being globally.

Products and Services
  • Pharmaceuticals: Therapeutic drugs for central nervous system, oncology, and infectious diseases
  • Nutraceuticals: Nutrition products, health drinks, and dietary supplements
  • Consumer Products: Mineral water, food, and beverages
Growth Outlook
  • Pharmaceutical segment growth driven by increasing demand for CNS and oncology treatments
  • Expansion in nutraceuticals aligns with rising health consciousness among consumers
  • Strategic investments in R&D to enhance product pipeline and market reach
Financial Highlights
  • Recent quarterly revenue of 641.92 billion JPY, reflecting strong market performance
  • Trailing twelve months (TTM) net profit margin of 14.96%, indicating efficient operations
  • TTM return on equity of 12.85%, showcasing effective use of shareholder funds
Otsuka Holdings Co., Ltd. has established a strong presence in the healthcare sector, with a diverse portfolio that caters to various market needs. The company's focus on research and development, particularly in pharmaceuticals, positions it well for future growth. Recent financial performance highlights a robust revenue stream and solid profit margins, reflecting operational efficiency and market demand. The strategic direction towards expanding nutraceuticals and consumer products further enhances growth potential, making Otsuka Holdings a noteworthy consideration for investors interested in the healthcare industry.
AI Generated • Jul 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

37,758

CEO

Makoto Inoue

Website

www.otsuka.com

Headquarters

Tokyo, TY 101-0048, JP

OTSKY Financials

Key Financial Metrics (TTM)

Gross Margin

71.78%

Operating Margin

17.26%

Net Income Margin

15.46%

Return on Equity

13.24%

Return on Capital

13.25%

Return on Assets

9.22%

Earnings Yield

6.90%

Dividend Yield

0.64%

Payout Ratio

18.84%

Stock Overview

Market Cap

$36.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.05B

Volume

50.66K

Avg. Volume

43.04K

Financials (TTM)

Gross Profit

¥1.91T

Operating Income

¥459.76B

EBITDA

¥625.50B

Operating Cash Flow

¥417.70B

Capital Expenditure

-¥89.42B

Free Cash Flow

¥328.28B

Cash & ST Invst.

¥505.94B

Total Debt

¥194.20B

Otsuka Performance Analysis

Otsuka annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 13,213,935,879-3.1%
20232023-12-31JPY 14,355,494,6778.6%
20242024-12-31JPY 15,379,137,8237.1%
20252025-12-31JPY 16,503,342,2187.3%
Otsuka sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.6%
Q42025-12-312.0%
Q12026-03-31-3.0%
Q22026-06-3010.8%
Otsuka annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 0.94-10.8%
20232023-12-31JPY 0.80-15.1%
20242024-12-31JPY 2.09162.5%
20252025-12-31JPY 2.299.5%
Otsuka sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3042.6%
Q42025-12-31-47.5%
Q12026-03-3150.3%
Q22026-06-3019.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

¥711.29B

+19.0%

Gross Profit

¥516.95B

+20.5%

Gross Margin

72.68%

N/A

Market Cap

$36.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$961.04K

N/A

Employees

37,758

N/A

Net Income

¥118.81B

+34.2%

EBITDA

¥179.15B

+33.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

¥505.94B

+15.9%

Total Debt

¥194.20B

-8.2%

Accounts Receivable

¥590.22B

+18.1%

Inventory

¥413.91B

+18.1%

Long Term Debt

¥164.66B

+7.1%

Short Term Debt

¥29.55B

-48.8%

Return on Assets

9.22%

N/A

Return on Invested Capital

12.37%

N/A

Free Cash Flow

¥89.95B

+10.1%

Operating Cash Flow

¥110.03B

+2.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDZNYSandoz Group AG
$81.48-2.90%
FSNUFFresenius SE & Co. KGaA
$54.35+0.00%
ALPMFAstellas Pharma Inc.
$14.75-3.91%
ALPMYAstellas Pharma Inc.
$13.73-5.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
FCUVFocus Universal
$11.60+5.17%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$23.67-0.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.62+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.73-0.02%

Questions About OTSKY

What is the current price of Otsuka?

Otsuka is trading at $34.41 per share.

What is the 52-week range for Otsuka?

Over the past 52 weeks, Otsuka has traded between $24.91 and $37.52.

How much debt does Otsuka have?

As of the most recent reporting period, Otsuka reported total debt of ¥1.19B.

How much cash does Otsuka have on hand?

Otsuka reported ¥2.89B in cash and cash equivalents in its most recent financial results.

What is Otsuka’s dividend yield?

Otsuka currently has a dividend yield of 0.64%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services